1. Home
  2. CCCC vs MDV Comparison

CCCC vs MDV Comparison

Compare CCCC & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • MDV
  • Stock Information
  • Founded
  • CCCC 2015
  • MDV 2015
  • Country
  • CCCC United States
  • MDV United States
  • Employees
  • CCCC N/A
  • MDV N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • MDV Transportation Services
  • Sector
  • CCCC Health Care
  • MDV Consumer Discretionary
  • Exchange
  • CCCC Nasdaq
  • MDV Nasdaq
  • Market Cap
  • CCCC 175.1M
  • MDV 147.6M
  • IPO Year
  • CCCC 2020
  • MDV 2022
  • Fundamental
  • Price
  • CCCC $2.71
  • MDV $15.01
  • Analyst Decision
  • CCCC Buy
  • MDV
  • Analyst Count
  • CCCC 3
  • MDV 0
  • Target Price
  • CCCC $8.00
  • MDV N/A
  • AVG Volume (30 Days)
  • CCCC 1.2M
  • MDV 38.8K
  • Earning Date
  • CCCC 10-30-2025
  • MDV 11-05-2025
  • Dividend Yield
  • CCCC N/A
  • MDV 7.80%
  • EPS Growth
  • CCCC N/A
  • MDV N/A
  • EPS
  • CCCC N/A
  • MDV N/A
  • Revenue
  • CCCC $34,240,000.00
  • MDV $47,273,000.00
  • Revenue This Year
  • CCCC N/A
  • MDV $1.72
  • Revenue Next Year
  • CCCC N/A
  • MDV $3.86
  • P/E Ratio
  • CCCC N/A
  • MDV N/A
  • Revenue Growth
  • CCCC 16.55
  • MDV N/A
  • 52 Week Low
  • CCCC $1.09
  • MDV $13.62
  • 52 Week High
  • CCCC $7.22
  • MDV $18.11
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 60.68
  • MDV 50.98
  • Support Level
  • CCCC $2.57
  • MDV $15.00
  • Resistance Level
  • CCCC $2.85
  • MDV $15.40
  • Average True Range (ATR)
  • CCCC 0.19
  • MDV 0.30
  • MACD
  • CCCC -0.01
  • MDV -0.02
  • Stochastic Oscillator
  • CCCC 72.88
  • MDV 40.51

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

Share on Social Networks: